Not reviewed. This deck cannot be opened, downloaded or sent
until you approve it. Read every point and its source first — they were drafted
from search results, not from clinical judgement.
Succinylcholine 1 mg/kg and rocuronium 0.6 mg/kg produced intubating conditions at 60 seconds that a blinded assessor could not tell apart, but succinylcholine both arrived and left faster: twitch depression to 5% of control took 0.8 minutes versus 1.2 minutes, and recovery to 90% of control twitch took 11.3 minutes after succinylcholine against 36.1 minutes after rocuronium.
The Cochrane review of 50 trials and 4,151 patients found succinylcholine superior to rocuronium for achieving excellent intubating conditions in rapid sequence induction (risk ratio 0.86), with no statistical difference against rocuronium 1.2 mg/kg — where succinylcholine remained clinically superior only because of its shorter duration of action.
The dose of rocuronium buys speed and pays for it in time: in patients over 80, 0.9 mg/kg reached a train-of-four count of zero in 108 seconds and lasted 118 minutes, while 0.3 mg/kg took 228 seconds and lasted 46 minutes — and two-thirds of the low-dose patients never reached a count of zero at all.
Neostigmine antagonises block only where spontaneous recovery has already begun — the standing advice is to wait until at least the second twitch of the train-of-four is detectable, its full effect still takes up to 10 minutes, and because it works by flooding every muscarinic receptor in the body it must be given with an antimuscarinic, a pairing that is itself dose-dependently associated with postoperative tachycardia.
Sugammadex encapsulates rocuronium rather than out-competing it at the junction, so its dose is chosen from the depth of block — about 2 mg/kg once the second twitch has returned, 4 to 8 mg/kg at a post-tetanic count of 1 to 2, and 16 mg/kg for immediate reversal — and in a Cochrane meta-analysis of 41 trials it reached a train-of-four ratio above 0.9 in 2.0 minutes from the second twitch against 12.9 minutes for neostigmine, and in 2.9 minutes from a post-tetanic count of 1 to 5 against 48.8 minutes.
Choosing the better reversal drug helps but does not absolve you — a matched cohort of 45,712 American surgical patients found sugammadex associated with a 30% lower risk of major pulmonary complications than neostigmine, while a 22,803-patient European prospective study found that using a neuromuscular blocking agent at all was associated with more pulmonary complications, and neither monitoring, nor giving a reversal agent, nor extubating at a train-of-four ratio of 0.9 or more removed that association.
If you cannot intubate and cannot ventilate this patient, which relaxant do you wish you had given, and how long until it does not matter?
How deep is the block right now? Tell me what the monitor says, not what the clock says.
You have neostigmine and sugammadex on the cart. What decides which one — and what decides the dose?
He is lifting his head off the pillow. Is he reversed? How would you know if he were not?